Cytochrome P-450

1 clinical trials · Condition

Record	Firm	Date
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) (NCT05288166)	Eli Lilly and Company	2022-04-14

Every clearance here is in the API, with alerts when new ones post.